• Exvastat wins 3.6m euro grant for COVID-19 trial pharmatimes
    May 15, 2020
    Privately-held biopharma Exvastat (Ireland) Ltd has won a 3.6 million euro grant from the Innovative Medicines Initiative following its call for developers to repurpose imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by CO
PharmaSources Customer Service